Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1A (migalastat)1件: Migalastat1件: D10359 --1件: 19
2A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: D00276 ,
D00278 ,
D00424 		--1件: 96
3A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)----1件: 60
4A multistrain probiotic product (DSF)----1件: 97
5A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs----1件: 46
6A novel synthetic, orally-administered, non-peptide small molecule, which acts as----1件: 254
7A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R)----1件: 51
8A single blood sample for HLA typing----3件: 35, 38, 162
9A-1293543.74----1件: 96
10A-623----1件: 49
11A-623 or AMG 623----1件: 66
12A-dopamine1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
13A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299
14A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
15A01AC02----1件: 28
16A042917017----1件: 21
17A04AD10----1件: 298
18A07DA03----1件: 97
19A07EA06----1件: 66
20A10BK03----1件: 65
21A11HA02----1件: 93
22A16AB04----1件: 19
23A16AX06----1件: 19
24A16AX07----1件: 240
25A3907----1件: 94
26A4250----4件: 93, 296, 297, 338
27A4250 (1200 µg)----1件: 338
28A4250 (200 µg)----1件: 338
29A4250 (400 µg)----1件: 338
30A4250 (600 µg)----1件: 338
31A4250 (odevixibat)1件: Odevixibat1件: D11716 1件: SLC10A2 💬1件: Bile secretion 💬1件: 338
32A4250-015----1件: 297
33A4I Antagonist----1件: 13
34A: 1 dosis----1件: 97
35A: PTH (1-84)----1件: 235
36AAC Hexal----1件: 299
37Aadipose-Derived Mesenchymal Stem Cells----1件: 6
38AAV BBP-631----1件: 81
39AAV directed hLDLR gene therapy----1件: 79
40AAV-GAD Dose 1----1件: 6
41AAV-GAD Dose 2----1件: 6
42AAV-hAADC-2----1件: 6
43AAV-RPGR----1件: 90
44AAV1-gamma-sarcoglycan vector injection----1件: 113
45AAV2-GDNF----1件: 6
46AAV2-GDNF gene therapy----1件: 17
47AAV2-REP1----1件: 90
48AAV2/5-hPDE6B----1件: 90
49AAV2/5-hRKp.RPGR----1件: 90
50AAV2/5-RPGR----1件: 90
51AAV2/8.TBG.hARSB----1件: 19
52AAV2CUhCLN2 (3x10^12 particle units)----1件: 19
53AAV5-HRKP.RPGR----1件: 90
54AAV5-RPGR----1件: 90
55AAV5-RPGR 2e11----1件: 90
56AAV5-RPGR 4e11----1件: 90
57AAV8-RPGR----1件: 90
58AAV8.TBG.hLDLR----1件: 79
59AAV9 BBP-8121件: BBP-812---1件: 307
60AAV9-CAG-coh-SGSH----1件: 19
61AAV9-GLB1----1件: 19
62AAVLK03hOTC----1件: 251
63AAVrh.10-hMPSIIIA----1件: 19
64AAVrh.10cuARSA----1件: 19
65AAVrh.10CUCLN2----1件: 19
66AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies----1件: 19
67AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies----1件: 19
68AAVrh10.CAG.hCYP46A1----1件: 8
69AB (antibiotics)----1件: 97
70AB 1003----1件: 2
71AB-1001 Gene Therapy----1件: 8
72AB1010----6件: 2, 5, 6, 13, 46, 96
73ABA, open-label (OL)----1件: 46
74Abacavir1件: Abacavir1件: D07057 --4件: 2, 135, 265, 325
75Abacavir 300mg twice daily1件: Abacavir1件: D07057 --1件: 265
76Abacavir sulfate2件: Abacavir,
Sulfate ion		1件: D07057 --1件: 265
77Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		3件: D00353 ,
D00413 ,
D07057 		--1件: 265
78Abalimumab----1件: 97
79Abalimumab bio-originatore----1件: 107
80Abatacept1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300
81Abatacept (ABA)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 97
82Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)2件: Abatacept,
Methotrexate		2件: D00142 ,
D03203 		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
83Abatacept (BMS-188667)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
84Abatacept (CTLA4-Ig)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 44
85Abatacept (IV)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
86Abatacept (M3-M12)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
87Abatacept (SC)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
88Abatacept + csDMARD1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
89Abatacept + Methotrexate2件: Abatacept,
Methotrexate		2件: D00142 ,
D03203 		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
90Abatacept + Vaccines1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
91Abatacept Active Treatment1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 50
92Abatacept also known as Orencia also known as CTLA4-Ig1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 49
93Abatacept Delayed-Onset Treatment1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 50
94Abatacept Injection1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬2件: 11, 46
95Abatacept Placebo1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬2件: 46, 53
96Abatacept Prefilled Syringe1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46
97Abatacept SC1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 53
98Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab,
Tocilizumab		3件: D02596 ,
D02994 ,
D03203 		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46
99ABBV-006----1件: 97
100ABBV-066----2件: 96, 97
101ABBV-0805----1件: 6
102ABBV-105----2件: 46, 49
103ABBV-105, A-1519938.0----1件: 46
104ABBV-119----1件: 299
105ABBV-154----2件: 46, 96
106ABBV-2222----1件: 299
107ABBV-257----1件: 46
108ABBV-3067----1件: 299
109ABBV-323----2件: 53, 97
110ABBV-323 Dose A----1件: 97
111ABBV-323 Dose B----1件: 97
112ABBV-3373----1件: 46
113ABBV-576----1件: 299
114ABBV-668----1件: 97
115ABBV-8E12----2件: 5, 7
116ABBV-951----1件: 6
117ABBV-CLS-7262----1件: 2
118ABC----2件: 256, 265
119ABC/DTG/3TC STR - Tablet----1件: 256
120ABC008----1件: 15
121Abcertin----1件: 19
122ABELCET1件: Amphotericin B1件: D00203 --1件: 299
123Abelmoschus manihot----1件: 66
124Abemaciclib1件: Abemaciclib1件: D10688 2件: CDK4,
CDK6 💬		29件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Endocrine resistance, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬1件: 34
125Abetimus1件: Abetimus---1件: 49
126ABETIMUS SODIUM1件: Abetimus---1件: 49
127Abetimus sodium (LJP 394)1件: Abetimus---1件: 49
128AbGn-168H----1件: 97
129ABH0011件: ABH001---1件: 36
130ABI-M201----1件: 97
131Abiraterone1件: Abiraterone---2件: 75, 81
132Abiraterone Acetate2件: Abiraterone,
Acetate		---2件: 75, 81
133Abiraterone acetato1件: Abiraterone---1件: 75
134Abituzumab1件: Abituzumab---1件: 51
135Abituzumab 1500 mg1件: Abituzumab---1件: 51
136Abituzumab 500 mg1件: Abituzumab---1件: 51
137ABO-101----1件: 19
138ABO-102----1件: 19
139Abobotulinumtoxin A----1件: 13
140ABP 501----1件: 46
141ABP 710----1件: 46
142ABP 710 - Biosimilar to infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
143ABP 798----1件: 46
144ABP 798 - Biosimilar to rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
145ABP 798 Biosimilar to Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
146ABP 959----1件: 62
147ABP 959 - biosimilar to eculizumab1件: Eculizumab1件: D03940 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62
148ABP 959 - proposed biosimilar to eculizumab1件: Eculizumab1件: D03940 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62
149ABPC1件: Ampicillin1件: D00204 --1件: 84
150ABR-215062----1件: 13
151ABR-215062 sodium salt----2件: 13, 96
152ABR-215757----2件: 49, 51
153Abrilumab1件: Abrilumab1件: D10540 2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97
154Abrocitinib1件: Abrocitinib1件: D11400 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84
155Abrocitinib 200 mg1件: Abrocitinib1件: D11400 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84
156ABT 494----1件: 46
157ABT 494 12mg----2件: 46, 96
158ABT 494 3mg----2件: 46, 96
159ABT Humira----1件: 96
160ABT-122----1件: 46
161ABT-199----1件: 49
162ABT-494----7件: 41, 46, 49, 96, 97, 107, 271
163ABT-494 15mg----1件: 46
164ABT-494 30mg----1件: 46
165ABT-555----1件: 13
166ABT-874----1件: 96
167ABT-874/Human monoclonal antibody against IL-12----1件: 13
168ABT-Humira1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97
169ABT-SLV187----1件: 6
170ABX-14311件: ABX-1431---1件: 13
171ABX-1431 HCl1件: ABX-1431---1件: 13
172ABX464----3件: 46, 96, 97
173ABX464 100mg----2件: 46, 97
174ABX464 25mg----1件: 97
175ABX464 50mg----2件: 46, 97
176ABY-035----1件: 271
177AC-203----1件: 36
178AC-203 1% Topical Ointment----1件: 162
179AC0058TA----1件: 49
180AC430----1件: 46
181Acalabrutinib1件: Acalabrutinib1件: D10893 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 46, 61
182Acamprosate1件: Acamprosate1件: D07058 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 206
183Acarbose1件: Acarbose1件: D00216 5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298
184Acazicolcept----1件: 49
185ACC----1件: 299
186ACC600Tabs----1件: 299
187Accelerated 1 hour-infusion----2件: 96, 97
188Accelerated 30 minutes-infusion----2件: 96, 97
189Access program - sildenafil citrate, Viagra, Revatio1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
190Accordion Pill Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
191Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
192Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
193Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
194Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
195Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
196Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
197Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
198Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
199Accupro----1件: 19
200Accuretic1件: Quinapril1件: D03752 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 19
201ACE I, ATA II and Statins----1件: 218
202ACE inhibitor----1件: 66
203ACE inhibitor + statin----1件: 66
204ACE Inhibitor or Angiotensin receptor antagonist1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66
205ACE-011----1件: 86
206ACE-011 / MK - 7962----1件: 86
207ACE-011 / MK-7962----1件: 86
208ACE-011/ MK-7962----1件: 86
209ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113
210ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113
211ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113
212ACE-031 0.5 mg/kg q4wk----1件: 113
213ACE-031 1.0 mg/kg q2wk----1件: 113
214ACE-083----2件: 10, 113
215ACE-inhibitor----1件: 218
216ACE/ARB----1件: 66
217Acebilustat1件: Acebilustat---1件: 299
218Aceclofenac1件: Aceclofenac1件: D01545 3件: PTGES,
PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
219ACEi----2件: 66, 224
220ACEI/ARB and corticosteroids----1件: 66
221Acellbia----1件: 46
222ACENEURAMIC ACID1件: Aceneuramic acid1件: D11016 --1件: 30
223Aceneuramic Acid Extended-Release1件: Aceneuramic acid1件: D11016 --1件: 30
224Aceneuramic acid extended-release (Ace-ER)1件: Aceneuramic acid1件: D11016 --1件: 30
225Aceneuramic Acid Extended-Release Tablets1件: Aceneuramic acid1件: D11016 --1件: 30
226ACER-002 (celiprolol) 200 mg BID1件: Celiprolol1件: D07660 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 168
227Acetamide1件: Acetamide---2件: 86, 154
228Acetaminophen1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
229Acetaminophen Tablet 650mg1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
230Acetaminophen tablets1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
231Acetaminophen/paracetamol1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 35, 49
232Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
233ACETATO DI AMMONIO----1件: 97
234Acetazolamide1件: Acetazolamide1件: D00218 13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬6件: 13, 90, 115, 155, 225, 230
235Acetazolamide Sandoz 2501件: Acetazolamide1件: D00218 13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 225
236Acetic acid1件: Acetic acid1件: D00010 --1件: 97
237Acetohydroxamic Acid1件: Acetohydroxamic acid1件: D00220 --1件: 251
238Acetohydroxamic Acid Oral Tablet [Lithostat]1件: Acetohydroxamic acid1件: D00220 --1件: 251
239Acetominofene----2件: 11, 63
240Acetominophen----1件: 63
241ACETYL- L- CARNITINE1件: Levocarnitine1件: D02176 --1件: 265
242Acetyl-L-carnitine2件: Acetylcarnitine,
Levocarnitine		1件: D02176 --1件: 298
243Acetyl-L-carnitine 1000mg 2X per day for 3 months2件: Acetylcarnitine,
Levocarnitine		1件: D02176 --1件: 298
244Acetyl-l-leucine2件: L-Acetylleucine,
Leucine		1件: D00030 --2件: 19, 65
245Acetylcarnitine1件: Acetylcarnitine---2件: 2, 265
246Acetylcysteine1件: Acetylcysteine1件: D00221 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
247Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: D00221 --1件: 85
248ACETYLCYSTEINE SODIUM1件: Acetylcysteine1件: D00221 --1件: 299
249ACETYLSALICYLIC ACID1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210
250Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
251ACH-0144471----2件: 62, 222
252ACH-0144471 compresse----1件: 222
253ACH-0145228----1件: 62
254ACH0144471----1件: 222
255ACH0144471 compresse----1件: 222
256ACHIM----1件: 51
257ACHIM as solute (10^9 intestinal microbes/ml)----1件: 51
258ACHIM capsules----1件: 51
259Aciclin----1件: 28
260Aciclovir1件: Acyclovir1件: D00222 --3件: 13, 28, 60
261Acid mycophenolic (Myfortic)1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222
262Acide folique1件: Folic acid1件: D00070 --1件: 46
263ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299
264ACIDO ASCORBICO----1件: 10
265ACIDO ASCORBICO DC.IT----1件: 10
266ACIDO DEOSSICOLICO----1件: 94
267Acido fusidico1件: Fusidic acid1件: D04281 --1件: 272
268ACIDO FUSIDICO/IDROCORTISONE ACETATO1件: Fusidic acid1件: D04281 --1件: 272
269Acido Micofenolico1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49
270Acido Obeticolico----2件: 93, 94
271Acido Sialico - Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: D11016 --1件: 30
272ACIDO TAUROURSODESOSSICOLICO----1件: 2
273Acido ursodessicolico----1件: 93
274Acidophilus1件: Lactobacillus acidophilus1件: D04349 --2件: 6, 97
275Acidum ascorbicum1件: Ascorbic acid1件: D00018 --1件: 206
276ACIDUM ASCORBICUM D61件: Ascorbic acid1件: D00018 --1件: 206
277Acipimox1件: Acipimox1件: D07190 --2件: 78, 265
278Acitretin1件: Acitretin1件: D02754 5件: RARA,
RARB,
RXRA,
RXRB,
RXRG 💬		19件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 37
279Aclasta----3件: 13, 271, 274
280Aclasta 5 mg Infusionslösung1件: Zoledronic acid2件: D01968 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13
281Aclasta 5mg solution for infusion----1件: 13
282ACM----1件: 49
283ACN00177----1件: 337
284Acomplia1件: Rimonabant1件: D05731 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193
285ACOMPLIA 20 mg film-coated tablets1件: Rimonabant1件: D05731 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193
286Acoramidis----1件: 28
287Acotiamide1件: Acotiamide---1件: 51
288Acoziborole1件: Acoziborole---1件: 65
289Acoziborole (SCYX-7158)1件: Acoziborole---1件: 65
290ACP-001----1件: 78
291ACP-001 (TransCon hGH)----1件: 78
292ACP-011----1件: 78
293ACP-103----1件: 6
294ACR16----1件: 8
295ACR16 10 mg----1件: 8
296ACR16 22.5 mg----1件: 8
297ACR16 45 mg----1件: 8
298ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8
299ACR3251件: ACR325---1件: 6
300ACT----1件: 13
301ACT - 064992----1件: 86
302ACT-050089----1件: 86
303ACT-050089 (Ro 61-0612)----1件: 86
304ACT-064992----5件: 51, 85, 86, 88, 210
305ACT-064992 (macitentan)1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
306ACT-064992 / JNJ-67896062----1件: 86
307ACT-064992/ JNJ-67896062----1件: 86
308ACT-064992D----1件: 86
309ACT-1----1件: 13
310ACT-128800----1件: 13
311ACT-128800 Dose 1----1件: 13
312ACT-128800 Dose 2----1件: 13
313ACT-128800 Dose 3----1件: 13
314ACT-178418----1件: 86
315ACT-293987----3件: 51, 86, 88
316ACT-293987 (NS-304)----1件: 86
317ACT-293987 / JNJ-67896049----1件: 84
318ACT-334441----1件: 49
319ACT-385781A----1件: 86
320ACT-385781A (Actelion Epoprostenol)1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
321ACT-434964----1件: 19
322Act-HiB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 14, 61, 62, 222
323ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 61, 62
324Actemra1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
325Actemra(EU-licensed)1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
326Actemra, MRA1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107
327Acteoside1件: Acteoside---1件: 66
328ACTH1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 13, 66, 145, 222
329ACTH (Acthar) Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66
330Acthar1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222
331Acthar 80 unit injection1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66
332Acthar Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 46, 49, 50, 84, 222
333ACTHAR Gel (ACTH)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
334ACTHAR Gel (adrenocorticotropic hormone)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
335ACTHAR Gel 40 units twice weekly1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
336ACTHAR Gel 80 units twice weekly.1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
337Acthar high dose (80 U)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49
338Acthar Injectable Product1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 46
339Acthar low dose (40 U)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49
340ActHIB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66
341ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66
342Acthrel1件: Corticorelin ovine triflutate1件: D03592 2件: CRHR1,
CRHR2 💬		4件: Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
343ACTIMMUNE1件: Interferon gamma-1b1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 326
344Actimmune Registry1件: Interferon gamma-1b1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 326
345Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.----1件: 276
346Active comparator----2件: 6, 46
347Active Comparator receiving Extavia®1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
348Active Control----1件: 13
349Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6
350Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin---1件: 6
351Active Investigational Treatment ENT-01----1件: 6
352Active topical NS2 1% dermatologic cream----1件: 160
353Active Treatment Group 7% Hypertonic Saline----1件: 299
354ActiveMatrix----1件: 70
355Actonel 5mg Film Coated Tablets1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
356Actonel Once a Week 35 mg film-coated tablets1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
357Actonel Once a week 5mg film coated tablets1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113
358Actonel/Optinate 5mg film-coated tablets1件: Risedronic acid1件: D08484 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
359ACTOS (Pioglitazone)1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 13
360Actos 15 mg1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
361Actos 30 mg1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
362Actos 45 mg1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2
363Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299
364Actrapid Penfill 100UI/ml----1件: 299
365ActRIIA-IgG1Fc----1件: 86
366ACTUS-101----1件: 256
367ACU-4429----1件: 301
368Acycloguanosine1件: Acyclovir1件: D00222 --2件: 46, 53
369Acyclovir1件: Acyclovir1件: D00222 --2件: 13, 28
370Acylated and unacylated ghrelin dosages1件: Lenomorelin---3件: 193, 201, 202
371ACZ885----7件: 46, 84, 106, 107, 108, 266, 267
372ACZ885 (investigational)----1件: 46
373ACZ885 150 mg (Canakinumab)1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 107
374ACZ885 Drug Substance----3件: 46, 106, 107
375ACZ885, 150mg/1.0ml----2件: 266, 267
376ACZ885D----1件: 108
377ACZ885G----1件: 107
378AD 452----1件: 46
379AD 452 18 mg tablet----1件: 46
380AD 452 4.5 mg Tablet----1件: 46
381AD 452 9 mg tablet----1件: 46
382AD-810N (zonisamide)1件: Zonisamide1件: D00538 8件: CACNA1G,
CACNA1H,
CACNA1I,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬1件: 6
383Ad26.COV2-S.02----1件: 299
384Ad26.COV2.S----7件: 13, 35, 46, 49, 50, 51, 107
385Ad5-CB-CFTR----1件: 299
386ADA gene transfer----1件: 65
387ADA PBSC----1件: 65
388ADA Umbilical Cord Blood Cells----1件: 65
389Adagen1件: Pegademase1件: D05384 --1件: 65
390Adalimuab, Etanercept, Tocilizumab, or Abatacept3件: Abatacept,
Etanercept,
Tocilizumab		3件: D00742 ,
D02596 ,
D03203 		5件: CD80,
CD86,
IL6R,
LTA,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬1件: 46
391Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬17件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271
392Adalimumab (20mg)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
393Adalimumab (40mg)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
394Adalimumab (ADA)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
395Adalimumab (D2E7)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 271
396Adalimumab (Humira)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 222, 271
397Adalimumab (HUMIRA®)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
398Adalimumab (up to 9 months exposure)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
399Adalimumab - GP20171件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
400Adalimumab - US licensed Humira1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
401Adalimumab 40 mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
402Adalimumab 40 mg eow or ew1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
403Adalimumab 40 mg sc every other week1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
404Adalimumab 40 mg subcutaneous (SC) every other week (EOW)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
405Adalimumab 40mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
406Adalimumab 40mg q2w1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
407Adalimumab 80 mg1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
408Adalimumab Ab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
409Adalimumab and Infliximab2件: Adalimumab,
Infliximab		2件: D02597 ,
D02598 		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
410Adalimumab and its biosimilars1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
411Adalimumab biosimilare1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107
412ADALIMUMAB HUMIRA1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
413Adalimumab Injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 40, 46, 96
414Adalimumab PFS and Pen1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
415Adalimumab PRN1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
416Adalimumab with methotrexate2件: Adalimumab,
Methotrexate		2件: D00142 ,
D02597 		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
417Adalimumab, current formulation1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
418Adalimumab, Etanercept, Golimumab or infliximab4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: D00742 ,
D02597 ,
D02598 ,
D04358 		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
419Adalimumab, new formulation1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
420Adalimumab, plus prednisone2件: Adalimumab,
Prednisone		2件: D00473 ,
D02597 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
421Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
422ADALIMUMAB-EU1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
423Adalimumab-Pfizer1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
424Adalimummab----1件: 46
425Adcirca1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
426ADCIRCA 20 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
427Adcirca®1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
428Adderall XR----1件: 13
429Adderall XR 10 mg----1件: 13
430Adderall XR 5mg----1件: 13
431Adefovir1件: Adefovir1件: D02768 --1件: 46
432Adempas1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299
433Adempas (Riociguat, BAY63-2521)1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88
434ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
435ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
436ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
437ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
438ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86
439Adempas 0.125 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299
440Adempas 0.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
441Adempas 0.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
442Adempas 1 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
443Adempas 1.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
444Adempas 1.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
445Adempas 1.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
446Adempas 2 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
447Adempas 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
448Adempas 2.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
449Adempas 2.5 mg Film Coated Tablet1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
450Adempas®1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88
451Adempas® 0.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
452Adempas® 1.0 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
453Adempas® 1.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
454Adempas® 2.0 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
455Adempas® 2.5 mg film-coated tablets1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
456Adempas¿ 0.5 mg compressa rivestita con film1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
457Adempas¿ 1.01件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
458Adempas¿ 1.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
459Adempas¿ 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
460Adempas¿ 2.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86
461Adenin1件: Adenine1件: D00034 --1件: 46
462ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE1件: Levothyroxine1件: D08125 2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 19
463Adeno-associated viral vector serotype 3B encoding shortened human ATP7B----1件: 171
464Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113
465Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113
466Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene----1件: 19
467Adeno-associated viral vector serotype 9 encoding human ATP7B----1件: 171
468ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 CONTAINING THE HUMAN CHOLESTEROL 24-HYDROXYLASE GENE1件: Cholesterol1件: D00040 --1件: 8
469Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal)----1件: 19
470Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal)----1件: 19
471Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
472Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector1件: Idursulfase1件: D04499 1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
473Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector----1件: 19
474Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector----1件: 19
475Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector----1件: 19
476ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE----1件: 8
477Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113
478Adeno-associated virus serotype hu68 containing the human GALC gene----1件: 19
479Adeno-associated virus serotype rh.10 expressing beta-galactosidase1件: Tilactase1件: D03348 --1件: 19
480ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113
481Adeno-associated virus type 2 vector encoding Rab escort protein 1----1件: 90
482Adeno-associated virus-CFTR vector----1件: 299
483Adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65
484Adenoviral Vector-Mediated Gene Transfer----1件: 251
485Adipate1件: Iron (III) oxide adipate---2件: 97, 228
486Adipose derived allogenic mesenchymal stem cells (adAMSC)----1件: 96
487Adipose derived mesenchymal stem cell----1件: 3
488Adipose derived mesenchymal stem cells----1件: 86
489Adipose derived stromal cells intravenously injected----1件: 39
490Adipose derived, autologous mesenchymal stem cells----1件: 97
491Adipose tissue-derived mesenchymal stem cells----1件: 97
492Adipose-cord mesenchymal stromal cells (A-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 97
493Adipose-derived stromal vascular fraction cells----1件: 6
494Adjunctive analgesics----1件: 70
495Adjunctive anti-depressants----1件: 70
496Adjuvant without active component----2件: 6, 17
497ADL58591件: ADL5859---1件: 46
498ADMINISTRATION----1件: 19
499Administration of a high dose of desipramine1件: Desipramine1件: D07791 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156
500Administration of a low dose of desipramine1件: Desipramine1件: D07791 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156
501Administration of an ACE-inhibitor or not----1件: 210
502Administration of Cimzia®1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
503Administration of drug (Interferon-gamma 1-b) subcutaneously----1件: 65
504Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil4件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: D00407 ,
D00473 ,
D00752 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 49
505Administration of methylprednisolone, paracetamol and dexchlorpheniramine3件: Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone		3件: D00217 ,
D00407 ,
D07803 		4件: HRH1,
NR3C1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49
506Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab		2件: D00407 ,
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51
507Administration of stable isotope-labelled leucine-1件: Leucine1件: D00030 --1件: 6
508Adoport----1件: 222
509Adrabetadex1件: Adrabetadex---1件: 19
510Adrenal cortical hormone----1件: 224
511Adrenalina----1件: 299
512Adrenergic receptor binder (ARB)----1件: 224
513Adrenocorticotrophic hormone ACTH1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222
514Adrenocorticotropic Hormone1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 13, 50, 84
515Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
516Adrenocorticotropic Hormone Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 50
517Adrenocorticotropin hormone----1件: 145
518Adrulipase----1件: 299
519ADS-001----1件: 231
520ADS-5102----2件: 6, 13
521ADS-5102 (extended release amantadine HCl)1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
522ADS-5102, 137 mg----1件: 13
523ADS-5102, 274 mg----1件: 13
524ADSVF----2件: 15, 96
525ADSVF application in the right hand----1件: 51
526Adult human mesenchymal stem cells1件: Remestemcel-L1件: D09719 --2件: 85, 96
527Advagraf 0,5mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
528Advagraf 1mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
529Advagraf 5mg1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
530Advagraf prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
531ADVATE1件: Antihemophilic factor, human recombinant---1件: 288
532ADVATE (rAHF - PFM)1件: Antihemophilic factor, human recombinant---1件: 288
533ADVATE (rAHF-PFM)1件: Antihemophilic factor, human recombinant---1件: 288
534ADVATE 1000 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288
535ADVATE 1000IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288
536ADVATE 500 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288
537Adverse Reactions of Gammagard subcutaneously at Week 12----1件: 65
538Adverse Reactions of Gammagard subcutaneously at Week 24----1件: 65
539Adverse Reactions of Gammagard subcutaneously at Week 36----1件: 65
540Adverse Reactions of Gammagard subdermally at Week 12----1件: 65
541Adverse Reactions of Gammagard subdermally at Week 24----1件: 65
542Adverse Reactions of Gammagard subdermally at Week 36----1件: 65
543ADVM-043----1件: 231
544ADX-102 1% Topical Dermal Cream (reproxalap)1件: Reproxalap1件: D11309 --1件: 160
545ADX-2191----1件: 90
546ADX-629----1件: 160
547ADX48621----1件: 6
548AEB071----1件: 97
549AEB071A----1件: 97
550AED----1件: 158
551AEGR-733----1件: 79
552AER-901 Solution for Nebulization----1件: 86
553AER002----1件: 299
554Aerolised Liposomal Ciclosporin A1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
555Aerolised Liposomal Ciclosporin A 10mg1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
556Aerolised Liposomal Ciclosporin A 5mg1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
557Aeroquin----1件: 299
558Aerosol interferon-gamma----1件: 85
559Aerosolized human Alpha-1 Antitrypsin----1件: 231
560Aerosolized iloprost1件: Iloprost1件: D02721 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
561Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299
562Aerosoltherapy----1件: 299
563AeroVanc----1件: 299
564AERT, (R)-Baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
565Aesculus Hippocastanum / Horse Chestnut1件: Horse chestnut1件: D12028 --1件: 210
566AEZS-130----1件: 78
567AEZS-130 (formerly ARD-07)----1件: 78
568AF056----1件: 206
569AF37702 Injection----1件: 283
570AF37702, Hematide1件: Peginesatide1件: D09946 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
571AFAMELANOTIDE1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬2件: 159, 254
572Afamelanotide (16 mg implant)1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 159
573Afamelanotide Implant1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254
574Afegostat1件: Afegostat1件: D09576 --1件: 19
575Afegostat tartrate1件: Afegostat1件: D09576 --1件: 19
576AFFITOPE® PD01A----1件: 6
577AFFITOPE® PD01A + Adjuvant----2件: 6, 17
578AFFITOPE® PD03A + Adjuvant----1件: 17
579Aficamten----1件: 58
580Afimetoran1件: Afimetoran1件: D11908 --1件: 49
581Afimetoran (10mg)1件: Afimetoran1件: D11908 --1件: 49
582Afimetoran (2.5mg)1件: Afimetoran1件: D11908 --1件: 49
583Afinitor1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬3件: 34, 89, 158
584Afinitor (everolimus)1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 137
585Afinitor 5mg Tablets1件: Everolimus1件: D02714 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158
586Aflibercept1件: Aflibercept1件: D09574 3件: PGF,
VEGFA,
VEGFB 💬		24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬2件: 90, 166
587AFQ056----3件: 6, 8, 206
588AFQ056 with L-dopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
589AFQ065----1件: 6
590Afucosylated IgG1 kappa monoclonal antibody----1件: 300
591AG011----1件: 97
592AG011 - Capsules----1件: 97
593AG011 - Enema----1件: 97
594AG10----1件: 28
595AG10 HCl----1件: 28
596Agalsidase----1件: 19
597AGALSIDASE ALFA1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
598Agalsidase Alpha1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
599AGALSIDASE BETA1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
600Agalsidase beta (GZ419828)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
601Agalsidase beta (recombinant form)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
602Agalsidase beta from Biosidus 1 mg/kg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
603AGALSIDASI ALFA----1件: 19
604AGALSIDASI BETA----1件: 19
605AGEE cream----1件: 13
606AGLE 102----1件: 36
607AGM 719----1件: 46
608AGN 203818----1件: 226
609Agomelatine1件: Agomelatine1件: D02578 3件: HTR2C,
MTNR1A,
MTNR1B 💬		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6
610Agomelatine or PIacebo1件: Agomelatine1件: D02578 3件: HTR2C,
MTNR1A,
MTNR1B 💬		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6
611Agri-King Synbiotic (AKSB)----1件: 96
612Agrippal S1 (Influenza vaccination)----1件: 46
613AGS-009----1件: 49
614AGT-181----1件: 19
615AGT-181 (HIRMAb-IDUA)----1件: 19
616AGT-182----1件: 19
617AGUA PARA PREPARACIONES INYECTABLES----1件: 78
618AHSC----1件: 13
619AIDSVAX® B/E----1件: 49
620AIMSPRO----2件: 13, 51
621AIN----1件: 13
622AIN457----8件: 13, 37, 41, 46, 56, 96, 107, 271
623AIN457, 150 mg----1件: 271
624AIN457, 150mg----1件: 37
625AIN457, 75 mg----1件: 271
626AIN457A----1件: 271
627AIN457F----3件: 46, 107, 271
628Air----3件: 85, 97, 193
629AIR DNase----1件: 299
630AIR DNase™----1件: 299
631AIR001----1件: 86
632AIR001 (sodium nitrite inhalation solution)1件: Nitrite---1件: 86
633AIR001 Inhalation Solution----1件: 86
634AIR001 Inhalation Solution (Expansion arm)----1件: 86
635AJ201----1件: 1
636AJG501----1件: 97
637AJG511----1件: 97
638AJM300----1件: 97
639Ajulemic acid1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
640AK002----1件: 98
641AK102----1件: 79
642AK106-0016161件: AK106-001616---1件: 46
643AK1320 MS----1件: 70
644AKBM-3031----1件: 49
645AKCEA-ANGPTL3-LRX----2件: 79, 265
646Aknemin----1件: 201
647Aknemin 50----1件: 201
648AKR-501, YM-477----1件: 63
649AKST4290----2件: 6, 162
650AL----11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127
651AL-108----1件: 5
652AL0011件: Latozinemab1件: D12427 1件: SORT1 💬3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬2件: 2, 127
653AL01211----1件: 67
654AL2846 capsules----1件: 34
655ALA----2件: 180, 286
656ALAC, inulin, FOS, and sodium butyrate2件: Butyric Acid,
Inulin		1件: D00171 --1件: 156
657Alanine1件: Alanine1件: D00012 --4件: 6, 13, 298, 299
658Albendazole1件: Albendazole1件: D00134 --1件: 96
659Albendazole (Eskazole)1件: Albendazole1件: D00134 --1件: 96
660Albumen1件: Egg white---1件: 96
661Albumin----3件: 2, 20, 51
662Albumin (Human) 20%, United States Pharmacopeia (USP)----1件: 231
663Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14
664Albumin solution----1件: 20
665ALBUMINE HUMAINE----1件: 96
666Albunorm® 5%,----1件: 20
667Albutein 5%----1件: 2
668Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299
669Albuterol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89
670Albuterol nebulizer1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89
671Albuterol.1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
672Albutropin----1件: 78
673Albúmina humana----1件: 2
674Alcohol1件: Ethanol1件: D06542 --3件: 58, 279, 298
675ALD518----1件: 46
676ALD518 monoclonal antibody (anti IL-6 mAb)----1件: 46
677ALDESLEUCHINA----1件: 49
678ALDESLEUKIN1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬4件: 49, 65, 96, 97
679Aldosterone1件: Aldosterone1件: D10528 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬1件: 222
680Aldurazyme1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
681Aldurazyme (laronidase)1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬2件: 19, 256
682Aldurazyme (Recombinant Human Alpha-L-Iduronidase)1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
683ALDURAZYME*INFUS 1FL 5ML 500U1件: Laronidase1件: D04670 1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
684Alefacept1件: Alefacept1件: D02800 1件: CD58 💬2件: Cell adhesion molecules, Epstein-Barr virus infection 💬6件: 37, 60, 65, 164, 284, 285
685ALEMTUZUMAB1件: Alemtuzumab1件: D02802 1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
686Alemtuzumab (already received by alemtuzumab cohort between 1991 and 19941件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 46
687Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 46
688Alemtuzumab (Campath )1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 60
689Alemtuzumab (Campath)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 15
690Alemtuzumab (GZ402673)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
691Alemtuzumab 0.2 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
692Alemtuzumab 0.3 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
693Alemtuzumab 12 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
694Alemtuzumab 24 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
695Alemtuzumab and Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 		2件: CD52,
MS4A1 💬		-1件: 60
696Alemtuzumab GZ4026731件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
697Alemtuzumab immunotherapy1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
698Alemtuzumab Injection1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
699Alemtuzumab Injection [Lemtrada]1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
700Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 		2件: CD52,
MS4A1 💬		2件: , Hematopoietic cell lineage 💬1件: 63
701Alendronat Teva----1件: 46
702Alendronate1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 19, 41, 46, 50, 271, 274, 299
703Alendronate sodium1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 19, 299
704Alendronate versus alfacalcidol (1-alpha OH vitamin D)3件: Alendronic acid,
Alfacalcidol,
Vitamin D		2件: D01518 ,
D07119 		2件: FDPS,
VDR 💬		9件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬3件: 41, 46, 50
705ALENDRONIC ACID1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 46, 274
706Alequel----1件: 96
707Alfa-manosidadas humana recombinante----1件: 19
708Alfacalcidol1件: Alfacalcidol1件: D01518 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬8件: 41, 46, 49, 50, 96, 107, 235, 238
709Alfacalcidol 2 micrograms/ml1件: Alfacalcidol1件: D01518 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107
710Alfuzosin1件: Alfuzosin1件: D07124 1件: ADRA1A 💬7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13
711Alga Dunaliella Bardawil----1件: 90
712Alga Dunaliella Bardawil powder----1件: 90
713Alga Dunaliella Bardawill----1件: 90
714Algin1件: Alginic acid1件: D02324 --1件: 97
715Alginate1件: Alginic acid1件: D02324 --2件: 53, 299
716Alginate oligosaccharide1件: Alginic acid1件: D02324 --1件: 299
717Alginic acid1件: Alginic acid1件: D02324 --1件: 51
718ALGLUCOSIDASE ALFA1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
719Alglucosidase Alfa (Genetical Recombination)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
720Alglucosidase alfa (GZ419829)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
721ALGLUCOSIDASE ALFA (MYOZYME)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
722Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA])1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
723Alglucosidase alfa GZ4198291件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
724Alglucosidase alpha----1件: 256
725ALGLUCOSIDASI ALFA UMANA RICOMBINANTE----1件: 256
726Alicaforsen1件: Alicaforsen---2件: 96, 97
727Alicalm (polymeric liquid formula)----1件: 96
728ALIROCUMAB1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
729Alirocumab SAR236553 (REGN727)1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
730ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE----1件: 19
731Aliskiren1件: Aliskiren1件: D03208 1件: REN 💬3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬3件: 66, 167, 222
732ALITRETINOIN1件: Alitretinoin1件: D02815 5件: RARA,
RARB,
RXRA,
RXRB,
RXRG 💬		19件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 49
733ALK-001----1件: 301
734ALK-001 (No generic name)----1件: 301
735Alkaline Phosphatase1件: Alkaline Phosphatase---4件: 46, 93, 97, 172
736Alkalinized Lidocaine-Heparin2件: Heparin,
Lidocaine		3件: D00358 ,
D07510 ,
D08127 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226
737ALKERAN1件: Melphalan1件: D00369 --2件: 28, 60
738ALKS 8700----1件: 13
739ALKS 8700 Delayed Release (DR)1件: Manganese citrate---1件: 13
740ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13
741All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
742All subjects will receive maraviroc 300mg orally twice a day for 6 weeks1件: Maraviroc1件: D06670 1件: CCR5 💬11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 84
743All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine----1件: 2
744All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-----1件: 2
745All-trans retinoic acid1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 94
746All-Trans Retinoid Acid(ATRA)1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 63
747ALLANTOIN1件: Allantoin1件: D00121 --1件: 36
748ALLANTOINA----1件: 36
749Allergy immunotherapy (allergy shots)----1件: 98
750Allo-APZ2-EB----1件: 36
751Allo-APZ2-OTS----1件: 36
752ALLO-ASC----1件: 96
753ALLO-ASC-CD----1件: 96
754ALLO-ASC-DFU----1件: 36
755ALLO-ASC-SHEET----1件: 36
756Allo-hMSCs----2件: 211, 299
757Allo-HSCT----1件: 20
758AlloGen-LI----1件: 70
759Allogeneic adipose tissue-derived mesenchymal stem cells----1件: 97
760ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED----5件: 36, 38, 53, 96, 162
761Allogeneic adipose tissue-derived MSC----1件: 36
762Allogeneic adipose tissue-derived stromal/stem cells----1件: 53
763Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)1件: Remestemcel-L1件: D09719 --1件: 85
764Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)----1件: 96
765Allogeneic bone marrow transplant----1件: 49
766Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)----1件: 6
767Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)----1件: 6
768Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)----1件: 6
769Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)----1件: 6
770Allogeneic Cardiosphere-Derived Cells (CAP-1002)1件: CAP-1002---1件: 113
771Allogeneic donor derived B-lymphocytes----1件: 60
772Allogeneic Human Cardiosphere-Derived Stem Cells----1件: 86
773Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----1件: 13
774ALLOGENEIC MESENCHYMAL PRECURSOR CELLS----1件: 46
775Allogeneic mesenchymal stem cell transplantation----1件: 171
776Allogeneic Mesenchymal Stem Cells----1件: 47
777Allogeneic Mesenchymal Stem Cells (AlloMSC)----2件: 51, 53
778Allogeneic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
779ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 49
780Allogeneic MSC (AlloMSC)----1件: 49
781ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED----1件: 90
782Allogeneic peripheral blood stem cell----1件: 65
783Allogeneic skin-derived ABCB5-positive mesenchymal stem cells----1件: 36
784Allogeneic Stem Cell Therapy----1件: 96
785Allogeneic Stem Cell Transplant----2件: 53, 56
786Allogeneic Stem Cell Transplantation----2件: 49, 84
787Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation----1件: 17
788Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation----1件: 17
789Allogeneic umbilical cord mesenchymal stem cells----1件: 13
790Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601----1件: 96
791Allogenic eASCs 5 million cells/ml suspension for injection CX601----1件: 96
792Allogenic eASCs 5 million cells/ml suspension for injection. CX601----1件: 96
793Allogenic eASCs 5 million/ml suspension for injection.----1件: 96
794ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS----1件: 251
795Allogenic mesenchymal stem cell isolated from adipose tissue----3件: 38, 96, 162
796Allogenic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
797Allogenic parathyroid cells----1件: 235
798Allopregnanolone1件: Brexanolone1件: D11149 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 205
799Allopurinol1件: Allopurinol1件: D00224 1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬7件: 6, 46, 57, 60, 66, 96, 97
800Allopurinol Sandoz 100 mg, tabletten1件: Allopurinol1件: D00224 1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 96
801ALLOPURINOL SODIUM1件: Allopurinol1件: D00224 1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 96
802AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226
803ALN-51547----1件: 28
804ALN-60212----1件: 79
805ALN-60519----1件: 254
806ALN-61444----1件: 231
807ALN-62643----2件: 62, 109
808ALN-65585----1件: 234
809ALN-77412----1件: 231
810ALN-AAT----1件: 231
811ALN-AAT02----1件: 231
812ALN-AS1----1件: 254
813ALN-CC5----4件: 11, 62, 66, 109
814ALN-GO1----1件: 234
815ALN-PCSSC1件: Inclisiran1件: D11931 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
816ALN-TTRSC----1件: 28
817AloASC----1件: 97
818Aloe1件: Aloe vera leaf---2件: 97, 226
819Aloe Barbadensis Miller1件: Aloe vera leaf---1件: 97
820Aloe vera1件: Aloe vera leaf---2件: 97, 226
821Aloe vera gel1件: Aloe vera leaf---1件: 97
822Alofisel1件: Darvadstrocel1件: D11397 --1件: 96
823Alogabat----1件: 201
824Alpelisib1件: Alpelisib1件: D11011 1件: PIK3CA 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 138
825Alpelisib (BYL719)1件: Alpelisib1件: D11011 1件: PIK3CA 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 138
826Alpha 1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231
827Alpha 1-proteinase inhibitor (human)1件: Alpha-1-proteinase inhibitor---1件: 231
828Alpha beta depletion----2件: 60, 284
829Alpha interferon----1件: 56
830Alpha Lipoic Acid1件: Lipoic acid---1件: 13
831Alpha-1 Antitrypsin (AAT)----1件: 231
832Alpha-1 Antitrypsin (human)----1件: 231
833Alpha-1 HC 100 mg----1件: 299
834Alpha-1 HC 200 mg----1件: 299
835Alpha-1 MP----1件: 231
836Alpha-1 proteinase inhibitor (human)----1件: 231
837ALPHA-1-ANTITRYPSIN1件: Alpha-1-proteinase inhibitor---1件: 231
838Alpha-2C AR antagonist----1件: 51
839Alpha-galactosidase A1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
840Alpha-glucosidase1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
841ALPHA-LIPOIC ACID1件: Lipoic acid---2件: 2, 13
842Alpha-lipoic acid and L-acetyl carnitine2件: Levocarnitine,
Lipoic acid		1件: D02176 --1件: 5
843Alpha-proteinase inhibitor----1件: 98
844Alpha-tocopherol2件: Tocopherol,
Vitamin E		2件: D02331 ,
D02332 		--2件: 49, 206
845Alpha-tocotrienol quinone1件: Tocotrienol---2件: 21, 156
846Alpha-tocotrienolquinone----1件: 18
847Alpha1-antitrypsin----1件: 13
848Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299
849Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299
850Alphanate1件: Von Willebrand factor human---1件: 288
851Alphanate 1000 I.U.1件: Von Willebrand factor human---1件: 288
852Alphanate 1500 I.U.1件: Von Willebrand factor human---1件: 288
853Alphanate SD/HT1件: Von Willebrand factor human---1件: 288
854ALPHANATE*INF 1F 1000UI+F 10ML1件: Von Willebrand factor human---1件: 288
855ALPHANATE*INF 1F 1500UI+F 10ML1件: Von Willebrand factor human---1件: 288
856ALPHANATE*INF 1F 250UI+F 5ML1件: Von Willebrand factor human---1件: 288
857ALPHANATE*INF 1F 500UI+F 5ML1件: Von Willebrand factor human---1件: 288
858ALPN-101----1件: 49
859Alprazolam1件: Alprazolam1件: D00225 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 8, 75
860Alprostadil1件: Alprostadil1件: D00180 1件: PTGER1 💬4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬2件: 51, 70
861ALRN-5281 0.015 mg/kg----1件: 78
862ALRN-5281 0.05 mg/kg----1件: 78
863ALRN-5281 0.15 mg/kg----1件: 78
864ALS patients genetic characterization----1件: 2
865Also referred to as 'MEDI2070'----2件: 96, 97
866Also referred to as MED2070----1件: 96
867Also referred to as MEDI2070----2件: 96, 97
868Alternative osteoporosis medications----1件: 274
869ALTH12-1:4----1件: 97
870ALTH12-2:4----1件: 97
871ALTRI FARMACI DEL SISTEMA NERVOSO----1件: 13
872Altropane1件: Altropane---1件: 6
873Altropane (123I) Injection1件: Altropane---1件: 6
874ALTROPANE®1件: Altropane---1件: 6
875ALTU-1351件: ALTU-135---1件: 299
876ALTU-238----1件: 78
877ALTUS-135----1件: 299
878Aluminium1件: Aluminium---2件: 11, 46
879Aluminium hydroxide3件: Aluminium,
Aluminum hydroxide,
Hydroxide ion		1件: D02416 --2件: 11, 46
880Aluminium phosphate3件: Aluminium,
Aluminium phosphate,
Phosphate ion		---1件: 46
881Aluminum1件: Aluminium---1件: 11
882Aluminum hydroxide3件: Aluminium,
Aluminum hydroxide,
Hydroxide ion		1件: D02416 --1件: 11
883Alvarez 2----1件: 37
884ALVELESTAT1件: Alvelestat---1件: 231
885Alvelestat oral tablet - dose 11件: Alvelestat---1件: 231
886Alvelestat oral tablet - dose 21件: Alvelestat---1件: 231
887Alvelestat tosylate1件: Alvelestat---1件: 231
888Alwextin cream----1件: 36
889ALX-0061----2件: 46, 49
890ALX-0061 150 mg/mL----1件: 49
891ALX-0061 Nanobody----1件: 46
892ALX-0081----1件: 64
893ALX-009----1件: 299
894ALX-0600----1件: 96
895ALX0081----1件: 64
896ALXN1102----1件: 62
897ALXN1103----1件: 62
898ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109
899ALXN1830----3件: 11, 35, 61
900ALXN1840----1件: 171
901ALXN1850----1件: 172
902ALXN2040----1件: 62
903ALXN2040 (ACH-0144471)----1件: 62
904ALXN2050----2件: 11, 62
905ALZT-OP1a (cromolyn)1件: Cromoglicic acid1件: D07753 --1件: 2
906AM-01----1件: 51
907Amantadin-ratiopharm 100mg----1件: 6
908AMANTADINE1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127
909Amantadine 300 mg1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
910Amantadine HCl ER1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
911Amantadine HCl Extended Release1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
912Amantadine HCl Extended Release Capsule1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
913AMANTADINE HYDROCHLORIDE1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 13
914Amantadine hydrochloride (HCl)1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
915Amantadine Level1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13
916Amantadine sulfate2件: Amantadine,
Sulfate ion		1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
917AMB-05X----1件: 85
918Ambirix----1件: 107
919Ambrisentan1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 51, 84, 85, 86, 88, 210, 211
920Ambrisentan - high dose1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
921Ambrisentan - low dose1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
922Ambrisentan 5 mg1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88
923Ambrisentan 5 mg film-coated tablets1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
924Ambrisentan 5mg film-coated tablets [marketed product]1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
925Ambrisentan plus Spironolactone2件: Ambrisentan,
Spironolactone		2件: D00443 ,
D07077 		2件: EDNRA,
NR3C2 💬		8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
926Ambrisentan Tablet1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
927AMBROSAN 60mg Tablets----1件: 6
928Ambroxol1件: Ambroxol1件: D07442 --2件: 6, 19
929Ambroxol Hydrochloride1件: Ambroxol1件: D07442 --2件: 6, 19
930AMBROXOL HYDROCHLORIDE PH. EUR.1件: Ambroxol1件: D07442 --1件: 19
931AMD3100----1件: 285
932AMDX2011P----2件: 2, 6
933American Ginseng2件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
934American ginseng extract HT-10012件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
935AMG 1081件: AMG 108---1件: 46
936AMG 139----1件: 96
937AMG 145----1件: 79
938AMG 1571件: Tezepelumab1件: D11771 1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98
939AMG 162----2件: 46, 274
940AMG 181----2件: 96, 97
941AMG 357----1件: 46
942AMG 407----2件: 56, 107
943AMG 531----1件: 63
944AMG 557----1件: 49
945AMG 557/MEDI5872----1件: 53
946AMG 570----2件: 46, 49
947AMG 592----3件: 46, 49, 97
948AMG 623----1件: 49
949AMG 714----1件: 46
950AMG 719----1件: 46
951AMG 785----1件: 274
952AMG 811----1件: 49
953AMG 827----2件: 46, 96
954AMG 827 140 mg----1件: 46
955AMG 827 210 mg----2件: 46, 96
956AMG 827 350 MG----1件: 96
957AMG 827 70 mg----1件: 46
958AMG 827 700 MG----1件: 96
959AMG-407----2件: 56, 107
960AMG145----1件: 79
961AMG157----1件: 98
962AMG181----1件: 97
963AMG407----2件: 56, 107
964AMG531----2件: 60, 63
965AMG592----2件: 46, 49
966AMG811----1件: 49
967Amgevita1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
968AMGEVITA (Adalimumab biosimilar )1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
969Amgevita 40 mg Injektionslösung im Fertigpen1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
970Amgevita 40 mg Injektionslösung in einer Fertigspritze1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
971Amgevita 40Mg Solution for Injection----2件: 96, 97
972AMGEVITA®1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
973AMIAS----1件: 67
974AMIFAMPRIDINA----2件: 3, 11
975Amifampridina fosfato----2件: 3, 11
976Amifampridine1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12
977Amifampridine Phosphate2件: Amifampridine,
Phosphate ion		1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12
978Amifampridine Phosphate 10 MG Oral Tablet2件: Amifampridine,
Phosphate ion		1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 3
979Amifostine1件: Amifostine1件: D00226 --1件: 28
980Amifostine trihydrate1件: Amifostine1件: D00226 --1件: 28
981AMIKACIN1件: Amikacin1件: D02543 --2件: 60, 299
982Amikacin nebulization1件: Amikacin1件: D02543 --1件: 299
983AMIKACIN SULFATE2件: Amikacin,
Sulfate ion		1件: D02543 --1件: 299
984Amikacina1件: Amikacin1件: D02543 --1件: 299
985Amikacina liposomal (Arikace?)1件: Amikacin1件: D02543 --1件: 299
986Amikacine1件: Amikacin1件: D02543 --1件: 299
987Amikacine nebulization1件: Amikacin1件: D02543 --1件: 299
988Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin1件: D02543 --1件: 299
989Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin1件: D02543 --1件: 299
990AMILASA----1件: 299
991Amiloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
992Amiloride HCl1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
993Amiloride Hcl 5mg Tab1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 67
994Amiloride Hydrochloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
995AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
996Amiloride Solution for Inhalation1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
997Amilostad----1件: 13
998Amilostad HCT----1件: 13
999Amilostad HCT tablets----1件: 13
1000Amino acids1件: Amino acids---3件: 70, 240, 298
1001Aminocaproic acid1件: Aminocaproic acid1件: D00160 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 70
1002Aminoglycoside----1件: 299
1003Aminohippurate1件: Aminohippuric acid1件: D06890 --1件: 67
1004Aminohippurate Sodium Inj 20%1件: Aminohippuric acid1件: D06890 --1件: 67
1005Aminolevulinic acid1件: Aminolevulinic acid1件: D07567 --4件: 34, 96, 180, 286
1006Aminophylline1件: Aminophylline1件: D00227 18件: ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 63
1007Aminopterin1件: Aminopterin---1件: 46
1008AMINOSALICYLIC ACID1件: Aminosalicylic acid1件: D00162 --2件: 96, 97
1009Amiodarone1件: Amiodarone1件: D02910 16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 28, 127
1010Amiselimod1件: Amiselimod1件: D10905 5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97
1011Amitriptylin1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1012Amitriptylin-CT1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1013Amitriptylin-ct Tabletten1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
1014Amitriptyline1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 78, 97, 226, 299
1015Amitriptyline hydrochloride1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 97
1016Amitriptyline, fluoxetine and tramadol alone (control group)3件: Amitriptyline,
Fluoxetine,
Tramadol		3件: D00326 ,
D07448 ,
D08623 		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78
1017Amivita----1件: 2
1018Amlodipine1件: Amlodipine1件: D07450 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 67, 298
1019Amlodipine (drug)1件: Amlodipine1件: D07450 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
1020Amlodipine Gel1件: Amlodipine1件: D07450 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
1021Ammonia1件: Ammonia1件: D02916 --2件: 6, 296
1022Ammonium (15N) chloride1件: Chloride ion---1件: 251
1023Ammonium chloride2件: Ammonium chloride,
Chloride ion		1件: D01139 --3件: 96, 107, 251
1024AMN107----2件: 34, 86
1025Amniotic Epithelial Cells1件: Amniotic Epithelial Cells---1件: 26
1026Amniotic Fluid Allograft----1件: 70
1027Amniotic membrane extract eye drops (AMEED)----1件: 53
1028Amorphous calcium carbonate3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: D00932 ,
D10802 		--1件: 235
1029Amoxapine1件: Amoxapine1件: D00228 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46
1030Amoxapine & dipyridamole2件: Amoxapine,
Dipyridamole		2件: D00228 ,
D00302 		4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬		8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
1031Amoxicilina1件: Amoxicillin2件: D00229 ,
D07452 		--1件: 46
1032Amoxicillin1件: Amoxicillin2件: D00229 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
1033Amoxicillin and Clavulanic acid1件: Clavulanic acid1件: D07711 --1件: 299
1034Amoxicillin and doxycyclin2件: Amoxicillin,
Doxycycline		4件: D00229 ,
D00307 ,
D07452 ,
D07876 		--1件: 97
1035Amoxicillin hydrate1件: Amoxicillin2件: D00229 ,
D07452 		--1件: 63
1036Amoxicillin, metronidazole and doxycycline3件: Amoxicillin,
Doxycycline,
Metronidazole		5件: D00229 ,
D00307 ,
D00409 ,
D07452 ,
D07876 		--1件: 97
1037Amoxycillin1件: Amoxicillin2件: D00229 ,
D07452 		--1件: 63
1038AMP----1件: 46
1039AMP-110----1件: 46
1040Ampalex----1件: 206
1041AMPC1件: Cyclic adenosine monophosphate---1件: 84
1042Amphotericin----1件: 299
1043Amphotericin B1件: Amphotericin B1件: D00203 --1件: 299
1044AMPHOTERICINE B, LIPOSOME----1件: 60
1045Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265
1046Ampreloxetine1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1047Ampreloxetine chydrochloride1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1048Ampreloxetine hydrochloride1件: Ampreloxetine1件: D11688 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17
1049Amprenavir1件: Amprenavir1件: D00894 --1件: 265
1050Ampyra1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 6, 13
1051Ampyra first,1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 6
1052AMSC----1件: 2
1053AMT----4件: 8, 46, 97, 321
1054AMT-101----2件: 46, 97
1055AMT-101 (oral)----1件: 97
1056AMT-1301件: AMT-130---1件: 8
1057AMX0035----2件: 2, 233
1058Amyl Nitrite2件: Amyl Nitrite,
Nitrite		1件: D00517 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58
1059Amyl nitrite inhalation2件: Amyl Nitrite,
Nitrite		1件: D00517 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58
1060AMYLASE----1件: 299
1061Amyvid1件: Florbetapir (18F)---2件: 13, 127
1062Amyvid radiopharmaceutical1件: Florbetapir (18F)---1件: 13
1063AMZ0021件: AMZ002---1件: 145
1064AN100226----2件: 13, 96
1065AN100226, BG00002----1件: 13
1066ANA001XHCl (Syntagon) or VEXA-04 (Patheon)----1件: 156
1067ANACETRAPIB1件: Anacetrapib1件: D08855 1件: CETP 💬1件: Cholesterol metabolism 💬1件: 79
1068Anaerobically Cultivated Human Intestinal Microbiota----1件: 51
1069Anaerobically Cultivated medium----1件: 51
1070Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
1071Anakinra (Kineret®)1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46
1072Anakinra (r-metHuIL-1ra)1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46
1073Anakinra / kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107
1074Anakinra and PEG sTNF-R12件: Anakinra,
Pegsunercept		2件: D02934 ,
D05393 		3件: IL1R1,
IL1R2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
1075Analysis of gamma globulin----1件: 84
1076Analysis of selected single nucleotide polymorphisms (SNPs)----1件: 46
1077ANASTROZOLE1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬3件: 78, 86, 193
1078Anatomical Landmark-guided Suprascapular Nerve Block----1件: 149
1079ANAVEX2-73----2件: 6, 156
1080ANAVEX2-73 (blarcamesine)1件: Blarcamesine1件: D11383 6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 156
1081ANAVEX2-73 oral liquid----1件: 156
1082ANB019----1件: 37
1083AND (Andrographolide)1件: Andrographolide---1件: 97
1084Andecaliximab----4件: 46, 96, 97, 299
1085AndoSan----2件: 96, 97
1086AndroGel 1 % Topical Gel----1件: 13
1087Androgel 10 grams of gel containing 100 mg of testosterone1件: Testosterone1件: D00075 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13
1088Androgens----1件: 60
1089ANDROGRAPHIS PANICULATA----1件: 97
1090ANDROGRAPHIS PANICULATA (ethanol extract)1件: Ethanol1件: D06542 --1件: 97
1091Andrographolide1件: Andrographolide---1件: 97
1092Andrographolides----1件: 13
1093Anesthetic Topical Adhesive Synera----1件: 13
1094Anfibatide1件: Anfibatide---1件: 64
1095ANG-3070----1件: 85
1096Angiotensin1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬7件: 17, 19, 46, 66, 86, 222, 224
1097Angiotensin blockade1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66
1098Angiotensin II1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222
1099Angiotensin receptor blockers1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 46
1100Angiotensin-(1-7)1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17
1101Angiotensin-converting enzyme (ACE) inhibitor1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224
1102Angiotensin-converting enzyme inhibitor(ACEI)1件: Angiotensin II2件: D00150 ,
D02014 		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224
1103Anhydrous Amiloride Hydrochloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225
1104ANHYDROUS CARBIDOPA1件: Carbidopa1件: D00558 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1105ANIFROLUMAB1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬3件: 46, 49, 53
1106Anifrolumab (MEDI-546)1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 46
1107Anifrolumab 1000 mg1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49
1108Anifrolumab 300 mg1件: Anifrolumab1件: D11082 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49
1109Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46
1110ANK-700----1件: 13
1111Anle138b1件: anle138b---1件: 6
1112Anrukinzumab1件: Anrukinzumab1件: D08857 1件: IL13 💬8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 97
1113Anti BAFF (B cell activating factor)----1件: 49
1114Anti Beta7----1件: 97
1115Anti CD3 monoclonal antibody----1件: 97
1116Anti human granulocyte-macrophage colo----1件: 46
1117Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL----1件: 46
1118Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody----1件: 46
1119Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46
1120Anti IL 6 mAb----1件: 46
1121Anti IL-1beta antibody----1件: 46
1122Anti IL-1beta antibody, subclass IgG4----1件: 46
1123Anti IL-1ß antibody----1件: 46
1124Anti IL-1ß antibody, subclass IgG4----1件: 46
1125Anti LP40 antibody, subclass IgG4----1件: 49
1126Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46
1127Anti LP40 anticuerpo, subclase IgG4----1件: 49
1128Anti Lymphotoxin Alpha----1件: 46
1129Anti Thymocyte Globulin----1件: 51
1130Anti TNF----1件: 96
1131Anti TNF + Meth----1件: 46
1132Anti TNF Alfa.----1件: 96
1133Anti TNF alpha agent----1件: 271
1134Anti TNF alpha therapy----1件: 271
1135Anti TNF humanized antibody Fab fragment-PEG conjugate----1件: 96
1136Anti TNF therapy including infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1137Anti-(complement C5a) IgG4 chimeric monoclonal antibody----1件: 269
1138Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain)----1件: 271
1139Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody----1件: 2
1140Anti-arrhythmic Drugs (AADs)----1件: 84
1141Anti-BAFFR antibody----1件: 95
1142Anti-Beta Interferon (PF-06823859)----1件: 50
1143Anti-blood dendritic cell antigen 2----1件: 49
1144Anti-C5 antibody----4件: 11, 14, 62, 109
1145Anti-C5aR----1件: 46
1146Anti-CD19-CAR-T cells----1件: 49
1147Anti-CD20 antibody----1件: 64
1148Anti-CD20 B cell depletion with Truxima----1件: 49
1149Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46
1150Anti-CD25 Humanized Monoclonal Antibody----1件: 13
1151Anti-CD28dAb----3件: 49, 53, 160
1152Anti-CD31件: Muromonab---2件: 96, 97
1153Anti-CD3 Monoclonal antibody1件: Muromonab---2件: 96, 97
1154Anti-CD40L1件: Toralizumab1件: D06193 1件: CD40LG 💬14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬1件: 63
1155Anti-CD40LdAb----1件: 63
1156Anti-CD45----3件: 60, 65, 285
1157Anti-CD52 monoclonal antibody----1件: 13
1158Anti-CT51 antigen mAb----1件: 51
1159Anti-D----1件: 63
1160Anti-GM-CSF receptor alpha----1件: 46
1161Anti-human immunoglobulin, equine----1件: 60
1162Anti-Human Interleukin-23 Monoclonal Antibody----1件: 271
1163Anti-human T-lymphocyte immunoglobulin from horse----1件: 60
1164ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS----1件: 51
1165Anti-hypertensive medications----1件: 67
1166Anti-IL-12----2件: 13, 96
1167Anti-IL-201件: Fletikumab1件: D11756 1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
1168Anti-IL-20 (109-0012)1件: Fletikumab1件: D11756 1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
1169Anti-IL-23 monoclonal antibody----1件: 96
1170Anti-IL-36R monoclonal antibody----1件: 37
1171Anti-IL-6 mAb----2件: 46, 96
1172Anti-IL6----1件: 46
1173Anti-inflammatory drugs----1件: 46
1174Anti-integrin alphaV mAb----1件: 51
1175Anti-Interferon-gamma monoclonal antibody----1件: 96
1176Anti-interleukin 5 (IL-5) humanized monoclonal----2件: 44, 45
1177Anti-interleukin-1B monoclonal antibody----1件: 106
1178Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----2件: 96, 97
1179Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----2件: 96, 97
1180Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----2件: 96, 97
1181Anti-Interleukin-6 Monoclonal----1件: 46
1182Anti-Interleukin-6 Monoclonal Antibody----2件: 46, 96
1183Anti-IP-10 Antibody----1件: 97
1184Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody----1件: 49
1185Anti-MAdCAM antibody----2件: 96, 97
1186Anti-Mullerian hormone (AMH) level----1件: 13
1187Anti-myostati----1件: 113
1188Anti-Myostatin Adnectin----1件: 113
1189Anti-pandemic H1N1 influenza vaccine----6件: 46, 49, 50, 51, 53, 107
1190Anti-Parkinson medication----5件: 5, 6, 7, 8, 17
1191Anti-Parkinsonian Drugs----1件: 6
1192Anti-pseudomonas IgY gargle----1件: 299
1193Anti-reflux pharmacotherapy----1件: 299
1194ANTI-SCLEROSTIN MONOCLONAL ANTIBODY----1件: 274
1195Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
1196Anti-thymocyte globulin (ATG)----1件: 164
1197Anti-thymocyte globulin (horse)----1件: 60
1198Anti-thymocyte globulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---3件: 60, 65, 285
1199Anti-Thymocyte Globulin, Rabbit2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 51
1200Anti-TL1A----1件: 97
1201Anti-TNF----4件: 46, 96, 107, 271
1202Anti-TNF agents----1件: 271
1203Anti-TNF biologics----2件: 46, 271
1204Anti-TNF Biologics Therapy----1件: 46
1205Anti-TNF discontinuation: Physiological saline solution----2件: 96, 97
1206Anti-TNF Drug----2件: 96, 97
1207Anti-TNF humanized antibody Fab fragment - PEG conjugate----1件: 46
1208Anti-TNF humanized antibody Fab' fragment - PEG conjugate----1件: 46
1209Anti-TNF suspended perioperatively----1件: 46
1210Anti-TNF therapy----3件: 46, 96, 97
1211Anti-TNF therapy (etanercept or adalimumab)2件: Adalimumab,
Etanercept		2件: D00742 ,
D02597 		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271
1212Anti-TNF-alpha----1件: 46
1213Anti-TNF: Infliximab (Infusion)1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1214Anti-TNF:Adalimumab (Subcutaneus)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
1215Anti-TNFa continued perioperatively----1件: 46
1216Anti-Tumor Necrosing Factor (TNF) Therapy----1件: 46
1217Anti-Tumor Necrosis Factor----1件: 271
1218Anti-Tumor Necrosis Factor Alpha Drug (Product)----1件: 46
1219Anti-tumor necrosis factor alpha monoclonal antibody----1件: 107
1220Anti-von Willebrand Factor Nanobody1件: Von Willebrand factor human---1件: 64
1221Anti-von Willebrand Factor Nanobody, Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: D11160 1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64
1222Anti-von Willebrand Factor Nanobody, INN = Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: D11160 1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64
1223Antiarrhythmic drugs----1件: 58
1224Antibiotic----1件: 299
1225Antibiotic cocktail----1件: 97
1226Antibiotic Regimen----1件: 84
1227Antibiotics----1件: 96
1228Anticholinergic medication----1件: 13
1229Anticorpo monoclonale anti GM-CSF umano----1件: 46
1230Anticorpo monoclonale anti IL-23----1件: 96
1231Anticorpo monoclonale anti-IL-23----1件: 96
1232Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2)----1件: 96
1233Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R.----1件: 46
1234Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13
1235Antiepileptic drug (1 to 3 only)----1件: 158
1236Antigen-specific T cells CART/CTL and DCvac----1件: 34
1237Antihemophilic Factor (Recombinant)----1件: 288
1238Antihistamine----2件: 13, 46
1239Antihistamine (cetirizine or equivalent)1件: Cetirizine1件: D07662 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 35
1240Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal----1件: 46
1241Antihypertensive drugs----1件: 67
1242Antilymphocyte serum----1件: 60
1243Antimicrobial therapy: Co-trimoxazole or Doxycycline1件: Doxycycline2件: D00307 ,
D07876 		--1件: 85
1244Antimycotic----1件: 13
1245Antioxidant Cocktail----1件: 299
1246Antioxidant plus Pregabalin1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 298
1247Antioxidants----3件: 90, 298, 310
1248Antiparkinsonian Agent(s)----1件: 6
1249Antiplatelets----1件: 124
1250Antipyretic----1件: 257
1251Antiretroviral/Anti HIV----1件: 265
1252Antisense oligonucleotide----1件: 5
1253Antistaminici H1 - H2----1件: 299
1254Antithymocyte----1件: 13
1255Antithymocyte Globulin----2件: 60, 284
1256Antithymocyte Globulin (ATG)----1件: 60
1257Antithymocyte globulin (Rabbit)1件: Rabbit---1件: 60
1258ANTITHYMOCYTE IMMUNOGLOBULIN1件: Antithymocyte immunoglobulin (rabbit)---2件: 13, 96
1259Antithymocyte immunoglobulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96
1260Antituberculous therapy along with steroids----1件: 84
1261Antivirale ad uso diretto----1件: 107
1262ANTOX----1件: 298
1263ANTOX (vers) 1.2----1件: 298
1264ANTOX (vers.)1.2----1件: 298
1265Antox version 1.2----1件: 298
1266ANX0051件: ANX005---3件: 2, 8, 61
1267Anxiety/depression and work and activities----1件: 13
1268Any other approved Antiepileptic Drug----1件: 144
1269AOC 1001----1件: 113
1270AOC 1020----1件: 113
1271AOC 1044----1件: 113
1272AODG (Apigenin-7-O-glucuronide)1件: Apigenin---1件: 97
1273AP----4件: 2, 6, 13, 299
1274AP-101----1件: 2
1275AP-CD/LD----1件: 6
1276AP-PA02----1件: 299
1277AP01----1件: 85
1278AP09004----1件: 6
1279AP1189----2件: 46, 222
1280AP1189, 100 mg----1件: 46
1281AP1189, 60 mg----1件: 46
1282AP1189, 80 mg----1件: 46
1283AP1903----3件: 60, 285, 326
1284AP1903 A594----3件: 60, 285, 326
1285Apabetalone1件: Apabetalone1件: D11131 4件: BRD2,
BRD3,
BRD4,
BRDT 💬		-1件: 86
1286Apadamtase alfa1件: Apadamtase alfa---1件: 64
1287Apademtase alfa----1件: 64
1288APCC, aPCC + TXA----1件: 288
1289APD334----5件: 93, 96, 97, 98, 269
1290APD334 L-arginine2件: Arginine,
L-arginine		1件: D02982 --1件: 97
1291APD371----1件: 96
1292APD421----1件: 107
1293APD811----1件: 86
1294Apelin----1件: 86
1295API----2件: 231, 299
1296API-AAT----1件: 231
1297API-AAT, AD00370, ARC-AAT, API drug Substance----1件: 231
1298Apigenin1件: Apigenin---2件: 6, 97
1299Apitegromab1件: Apitegromab1件: D11797 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 3
1300Apitox - pure honeybee toxin----1件: 13
1301Apixaban1件: Apixaban1件: D03213 1件: F10 💬1件: Complement and coagulation cascades 💬1件: 222
1302APL-130277----1件: 6
1303APL-1401----1件: 97
1304APL-2----5件: 2, 61, 62, 66, 222
1305APLA12----1件: 46
1306Aplindore1件: Aplindore---1件: 6
1307Aplindore MR tablets1件: Aplindore---1件: 6
1308APO-go----1件: 6
1309APO-go®----1件: 6
1310APO-P001----1件: 2
1311APOKINON----1件: 6
1312APOKYN1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1313Apomor----1件: 6
1314Apomorfina1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1315APOMORFINA CLORIDRATO1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1316Apomorp----1件: 6
1317Apomorphine1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7
1318Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1319Apomorphine HCl injection1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1320APOMORPHINE HYDROCHLORIDE1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1321Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1322Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1323Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1324Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1325APOMORPHINE HYDROCHLORIDE HEMIHYDRATE1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1326Apomorphine Hydrocloride1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1327Apomorphine Hydrocloride Hemihydrate1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1328Apomorphine infusion1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1329Apomorphine Injectable Solution1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1330Apomorphine Nasal Powder1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
1331APORON----1件: 6
1332ApoTamox 10mg----1件: 111
1333Application of Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
1334Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side1件: Sinecatechins1件: D08997 --1件: 160
1335Apraclonidine1件: Apraclonidine1件: D07461 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11
1336Apraclonidine Hcl 0.5% Oph Soln1件: Apraclonidine1件: D07461 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11
1337Apratastat1件: Apratastat1件: D08859 2件: ADAM17,
MMP13 💬		7件: Alzheimer disease, Coronavirus disease - COVID-19, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway 💬1件: 46
1338Apremilast1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬7件: 46, 50, 56, 97, 107, 162, 271
1339Apremilast (CC-10004)1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 56
1340Apremilast 10 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107
1341Apremilast 20 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107
1342Apremilast 30 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107
1343Apremilast 30mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 50
1344Apremilast tablet 20 mg1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271
1345Apremilast tablet 30 mg BID1件: Apremilast1件: D08860 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271
1346APRINOX----1件: 67
1347Apriso 0.375G ER CAP----1件: 97
1348APRISO 375 mg extended-release capsules1件: Manganese citrate---1件: 97
1349AProArt----1件: 65
1350Aprotinin1件: Aprotinin1件: D02971 --1件: 28
1351Aprovel1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167
1352Aprovel (150 mg)1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222
1353Aprovel 150 mg Tablets1件: Irbesartan1件: D00523 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222
1354APT-1011----1件: 98
1355APT-1011 - 3 mg----1件: 98
1356APT-1011 3 mg HS----1件: 98
1357APVO210----1件: 97
1358AQ280----1件: 98
1359AquADEK----1件: 299
1360AquADEKs-2----1件: 299
1361Aquamin----1件: 97
1362Aquamin®----1件: 97
1363AQW051----1件: 6
1364AQX-11251件: AQX-1125---1件: 226
1365AQX-1125 100 mg1件: AQX-1125---1件: 226
1366AQX-1125 200 mg1件: AQX-1125---1件: 226
1367AR-421件: AR-42---1件: 34
1368AR101----1件: 168
1369AR392830----1件: 86
1370AR401959 L-arginine2件: Arginine,
L-arginine		1件: D02982 --3件: 96, 97, 98
1371ARA 290----1件: 84
1372ARA290----1件: 46
1373Aramchol1件: Aramchol---1件: 265
1374ARAVA1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬3件: 46, 53, 162
1375Arava 20 mg filmdrasjerte tabletter----1件: 46
1376Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46
1377ARAVA®1件: Leflunomide1件: D00749 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46
1378ARB----1件: 66
1379Arbaclofen1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬2件: 13, 206
1380Arbaclofen ER Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1381Arbaclofen Extended Release Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1382Arbaclofen Placarbil2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1383Arbaclofen placarbil 15 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1384Arbaclofen placarbil 30 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1385Arbaclofen placarbil 45 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
1386ARC 1779----2件: 64, 288
1387ARC-AAT----1件: 231
1388ARC-AAT Injection----1件: 231
1389ARC1779----2件: 64, 288
1390ARC1779 Injection----2件: 64, 288
1391ARC1905----1件: 301
1392ARC1905 20 MG/ML----1件: 301
1393ARCOXIA----2件: 46, 271
1394ARCOXIA 90 mg comprimidos recubiertos con película----1件: 271
1395ARCT-032----1件: 299
1396ARCT-810----1件: 251
1397ARD-3150----1件: 299
1398Arginin----1件: 78
1399Arginina1件: Arginine1件: D02982 --2件: 58, 78
1400ARGININA CLORIDRATO1件: Arginine1件: D02982 --1件: 78
1401Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
1402ARGININE HYDROCHLORIDE1件: Arginine1件: D02982 --1件: 78
1403Argininhydrochlorid----1件: 65
1404ARGX-113----5件: 11, 14, 35, 53, 63
1405ARGX-117----1件: 14
1406ARGX-117 IV----1件: 14
1407ARICEPT1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 6, 13, 78, 124
1408Aricept 10 mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1409Aricept 10 mg filmdragerade tabletter1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1410Aricept 5 mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1411Aricept 5 mg filmdragerade tabletter1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
1412Aricept 5 mg-Filmtabletten----1件: 6
1413ARICEPT 5*28 CPR 5 MG1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 124
1414Aricept 5mg-Filmtabletten----1件: 6
1415Aridol1件: Mannitol1件: D00062 --1件: 299
1416Aridol or Osmohale1件: Mannitol1件: D00062 --1件: 299
1417ARIKACE™----1件: 299
1418Arikayce1件: Amikacin1件: D02543 --1件: 299
1419Arikayce™1件: Amikacin1件: D02543 --1件: 299
1420Arikayce™ 140 mg1件: Amikacin1件: D02543 --1件: 299
1421Arikayce™ 560 mg1件: Amikacin1件: D02543 --1件: 299
1422Arikayce™ 70 mg1件: Amikacin1件: D02543 --1件: 299
1423Arimidex1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬1件: 78
1424Arimidex (Anastrozole)1件: Anastrozole1件: D00960 1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬1件: 78
1425ARIMOCLOMOL1件: Arimoclomol1件: D11374 --3件: 2, 15, 19
1426Arimoclomol (hard gelatine capsule)2件: Arimoclomol,
Gelatin		3件: D00115 ,
D06892 ,
D11374 		--1件: 19
1427Arimoclomol (HPMC capsule)1件: Arimoclomol1件: D11374 --1件: 19
1428Arimoclomol citrate1件: Arimoclomol1件: D11374 --2件: 15, 19
1429ARINA-1----2件: 228, 299
1430Aripiprazole1件: Aripiprazole1件: D01164 4件: DRD2,
DRD3,
HTR1A,
HTR2A 💬		12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬2件: 6, 206
1431Arm 1 - GEH120714 (18F) Injection----1件: 13
1432Arm B: Rituxan®/Mabthera®1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
1433Armodafinil1件: Armodafinil1件: D03215 1件: SLC6A3 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84
1434ARN-6039----1件: 13
1435ARO-AAT----1件: 231
1436ARO-AAT Injection----1件: 231
1437ARO-ANG 3 Injection----1件: 79
1438ARO-C3----2件: 62, 66
1439ARO-ENaC----1件: 299
1440ARO-MMP7 Inhalation Solution----1件: 85
1441ARRY-371797----1件: 271
1442ARRY-371797, p38 inhibitor----2件: 46, 271
1443ARRY-438162----1件: 46
1444ARRY-438162, MEK inhibitor----1件: 46
1445ART-123----1件: 85
1446ART-I02----1件: 46
1447ART621----1件: 46
1448Artamin 150 mg----1件: 171
1449Artamin 250 mg----1件: 171
1450Artane----1件: 6
1451ARTEGENE drug product----1件: 65
1452Artesunate1件: Artesunate1件: D02482 --3件: 18, 66, 96
1453Artesunate Oral Product1件: Artesunate1件: D02482 --1件: 18
1454Arthroscopy & saline irrigation alone----1件: 46
1455Artificial Saliva----1件: 53
1456Artilog----1件: 46
1457Arundic Acid1件: Arundic acid1件: D06296 --1件: 2
1458ARX2011件: ARX201---1件: 78
1459Arylsulfatase A----1件: 19
1460Arzerra1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1461ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1462ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1463Arzerra®1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
1464AS----4件: 53, 96, 215, 271
1465AS2----1件: 6
1466ASA----3件: 13, 97, 251
1467ASACOL----1件: 97
1468Asacol (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1469Asacol (mesalamine) Delayed-release Tablets1件: Mesalazine1件: D00377 --1件: 97
1470Asacol 400 mg----1件: 97
1471Asacol 400 mg (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1472Asacol 400 mg tablet1件: Mesalazine1件: D00377 --1件: 97
1473Asacol 400mg tablet1件: Mesalazine1件: D00377 --1件: 97
1474Asacol 800 mg (mesalamine)1件: Mesalazine1件: D00377 --1件: 97
1475Asacol 800 mg tablet1件: Mesalazine1件: D00377 --1件: 97
1476Asacol 800mg tablet1件: Mesalazine1件: D00377 --1件: 97
1477Asacol Delayed Release Tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
1478Asacol Delayed-Release Tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
1479Asacol tablet1件: Mesalazine1件: D00377 --1件: 97
1480Asacol®1件: Mesalazine1件: D00377 --1件: 97
1481Asacol® 400 mg----1件: 97
1482ASASANTIN Retard----1件: 51
1483Asasantin Retard ®----1件: 51
1484ASB-683699----1件: 13
1485ASC----4件: 36, 51, 96, 97
1486ASC42 10 mg----1件: 93
1487ASC42 15 mg----1件: 93
1488ASC42 5 mg----1件: 93
1489Ascal(r) / carbasalate calcium2件: Calcium,
Carbaspirin calcium		1件: D03385 --1件: 46
1490Asceniv™----1件: 65
1491Ascorbic acid1件: Ascorbic acid1件: D00018 --4件: 10, 97, 206, 298
1492Ascorbic acid (Vitamin C)1件: Ascorbic acid1件: D00018 --1件: 10
1493Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)3件: Ascorbic acid,
Tocopherol,
Vitamin E		3件: D00018 ,
D02331 ,
D02332 		--1件: 206
1494Ascorbic acid vit C1件: Ascorbic acid1件: D00018 --1件: 10
1495ASCs----2件: 53, 96
1496ASCs: Adipose derived Stem Cells----1件: 96
1497Asendis----1件: 46
1498Asendis 50 mg----1件: 46
1499ASF-1096 Cream 0.25%----1件: 49
1500ASF-1096 Cream 0.5%----1件: 49
1501ASF-1096 Cream 1.0%----1件: 49
1502Asfotas Alfa----1件: 172
1503ASFOTASE ALFA1件: Asfotase alfa1件: D10595 1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172
1504Asfotase Alfa (ALXN1215)1件: Asfotase alfa1件: D10595 1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172
1505ASK Nr. 21972----1件: 5
1506ASK8007----1件: 46
1507ASP015K----2件: 46, 97
1508ASP015K hydrobromide----1件: 46
1509ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46
1510ASP1707----1件: 46
1511ASP2408----1件: 46
1512ASP2409----1件: 46
1513ASP3291----1件: 97
1514ASP3652----1件: 226
1515ASP5094----1件: 46
1516ASP6294----1件: 226
1517Asparaginase1件: Asparaginase Escherichia coli---1件: 65
1518Aspaveli1件: Pegcetacoplan1件: D11613 1件: C3 💬17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 62, 222
1519Aspergillus oryzae1件: Aspergillus oryzae---1件: 97
1520Aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231
1521Aspirin 650mg Oral Capsule1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
1522Aspirin 81mg tablet1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
1523Aspirin and meloxicam2件: Acetylsalicylic acid,
Meloxicam		2件: D00109 ,
D00969 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49
1524Aspirin tablet1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 64
1525Aspirin Tablets1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
1526Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53
1527Assigned pulmonary hypertension medication----1件: 86
1528AST-120----2件: 96, 97
1529Asthma patients----1件: 299
1530AstroRx----1件: 2
1531ASyn Mab----1件: 6
1532AT 10----2件: 6, 85
1533AT-1501----1件: 66
1534AT-GTX-501----1件: 19
1535AT1-inhibitor----1件: 218
1536AT1001----1件: 19
1537AT1001 150 mg----1件: 19
1538AT132----1件: 111
1539AT2101----1件: 19
1540AT22201件: AT2220---1件: 256
1541AT2221----1件: 256
1542AT2221 65 mg Formulated Capsules----1件: 256
1543AT845----1件: 256
1544ATA188----1件: 13
1545Atacicept1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 49, 66
1546Atacicept 150 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 49
1547Atacicept 25 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66
1548Atacicept 75 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66
1549Atacicept 75 milligram (mg)1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49
1550Atacicept150mg----1件: 66
1551Atacicept25mg----1件: 66
1552Atacicept75mg----1件: 66
1553Atacicept: with loading dose1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46
1554ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
1555Ataluren (PTC124®)1件: Ataluren1件: D09323 --1件: 299
1556Ataluren 1000 mg1件: Ataluren1件: D09323 --1件: 113
1557Ataluren 1000mg1件: Ataluren1件: D09323 --1件: 246
1558Ataluren 125 mg1件: Ataluren1件: D09323 --1件: 113
1559Ataluren 125mg1件: Ataluren1件: D09323 --1件: 246
1560Ataluren 250 mg1件: Ataluren1件: D09323 --1件: 113
1561Ataluren 250mg1件: Ataluren1件: D09323 --1件: 246
1562Atazanavir1件: Atazanavir1件: D07471 --1件: 265
1563Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		2件: D00427 ,
D07471 		--1件: 265
1564Atazanavir (Reyataz)1件: Atazanavir1件: D07471 --1件: 265
1565Atazanavir/Ritonavir2件: Atazanavir,
Ritonavir		2件: D00427 ,
D07471 		--1件: 265
1566ATB200----1件: 256
1567ATENOLOL1件: Atenolol1件: D00235 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167
1568Atenolol or Propranolol2件: Atenolol,
Propranolol		2件: D00235 ,
D08443 		3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167
1569Atezolizumab1件: Atezolizumab1件: D10773 1件: CD274 💬2件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬1件: 85
1570ATG----4件: 13, 60, 96, 285
1571ATG (rabbit)1件: Rabbit---1件: 11
1572ATG conditioning regimen----1件: 60
1573ATG+cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60
1574ATG+Rapamune+cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60
1575ATG-F----1件: 66
1576ATG-Fresenius----1件: 60
1577Atgam1件: Antilymphocyte immunoglobulin (horse)---1件: 60
1578ATGAM plus CsA with or without Eltrombopag1件: Eltrombopag---1件: 60
1579ATH-1017----1件: 6
1580ATH434----1件: 17
1581ATH434 dose level 1----1件: 17
1582ATH434 dose level 2----1件: 17
1583ATI-450----2件: 46, 106
1584ATI-450 20mg oral tablet BID----1件: 46
1585ATI-450 50mg oral tablet BID----1件: 46
1586ATL-25021件: ATL-2502---1件: 97
1587ATL11021件: ATL1102---1件: 13
1588ATM FOG in PD----1件: 6
1589ATN-103----1件: 46
1590ATN-103 10 mg q4wks----1件: 46
1591ATN-103 10 mg q8wks----1件: 46
1592ATN-103 30 mg q4wks----1件: 46
1593ATN-103 80 mg q4wks----1件: 46
1594ATN-103 80 mg q8wks----1件: 46
1595Atomexetine----1件: 17
1596Atomoxetine1件: Atomoxetine1件: D07473 1件: SLC6A2 💬1件: Synaptic vesicle cycle 💬4件: 6, 8, 13, 17
1597Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
1598Atorvastatin 10mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
1599Atorvastatin 20mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
1600Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet2件: Acetylcysteine,
Atorvastatin		2件: D00221 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
1601Atorvastatin 80mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 97
1602Atorvastatin Calcium2件: Atorvastatin,
Calcium		1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 97, 265
1603Atorvastatin tablet 20 mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 46
1604Atosiban1件: Atosiban1件: D03008 1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 118
1605ATOVAQUONE1件: Atovaquone1件: D00236 --1件: 61
1606ATR-101----2件: 75, 81
1607ATRA1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬2件: 63, 94
1608ATRASENTAN1件: Atrasentan---3件: 66, 218, 222
1609Atropina1件: Atropine1件: D00113 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
1610Atropine1件: Atropine1件: D00113 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2
1611ATV----1件: 265
1612ATX-MS-1467----1件: 13
1613Atypical Antipsychotics----1件: 6
1614ATYR19231件: ATYR1923---1件: 84
1615ATYR1923 1.0 mg/kg1件: ATYR1923---1件: 84
1616ATYR1923 3.0 mg/kg1件: ATYR1923---1件: 84
1617ATYR1923 5.0 mg/kg1件: ATYR1923---1件: 84
1618ATYR19401件: ATYR-1940---1件: 113
1619AUBAGIO1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1620AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1621AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1622Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1623Aubagio®1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
1624AUC of MPA measure----1件: 51
1625Augmentin1件: Clavulanic acid1件: D07711 --1件: 299
1626Aurexis----1件: 299
1627Aurexis® (tefibazumab)1件: Tefibazumab1件: D06054 --1件: 299
1628Auto Injector----1件: 46
1629Autoantibody Reductive Therapy----1件: 85
1630Autofluorescent detection + Injection of indocyanine green1件: Indocyanine green1件: D01342 --1件: 235
1631Autologous (self) mononuclear cells derived from umbilical cord blood----1件: 211
1632Autologous adipose derived mesenchymal cells----1件: 13
1633Autologous Adipose Derived MSCs (ADMSCs)----1件: 85
1634Autologous adipose derived stem cells----1件: 46
1635Autologous ADIpose derived stromal vascular fraction----1件: 96
1636Autologous Adipose Mesenchymal Stem Cell Implantation----1件: 17
1637Autologous Adipose-derived Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 2
1638Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded----1件: 2
1639Autologous adult bone marrow mononuclear cells unexpanded----1件: 2
1640Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13
1641Autologous apoptotic cells injection----1件: 46
1642Autologous ASC----1件: 51
1643Autologous bone marrow mononuclear cell transplantation----1件: 113
1644Autologous bone marrow mononucleated cells----1件: 2
1645Autologous Bone Marrow-Derived Mononuclear Stem Cells----1件: 13
1646Autologous bone marrow-derived stem cells----1件: 2
1647Autologous cardiac stem cells (JRM-001)----2件: 210, 211
1648Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene----1件: 65
1649AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65
1650AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19
1651Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19
1652AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20
1653Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65
1654Autologous CD34+ cells transduced with WASP lentiviral vector----1件: 65
1655Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65
1656Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII----1件: 19
1657Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65
1658AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65
1659Autologous CD34-selected peripheral blood stem cells transplant----1件: 96
1660Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13
1661Autologous cell-based delivery----1件: 211
1662Autologous EBV specific CTL infusion----1件: 49
1663Autologous EPCs transfected----1件: 86
1664Autologous EPCs transfected with human eNOS----1件: 86
1665Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65
1666Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA----1件: 20
1667Autologous Hematopoietic Stem Cell----1件: 13
1668Autologous Hematopoietic Stem Cell Transplantation----3件: 13, 49, 84
1669Autologous hematopoietic stem cells----1件: 13
1670Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70----1件: 46
1671Autologous Mesenchymal Cell Product----1件: 13
1672Autologous mesenchymal stem cell transplantation----1件: 13
1673Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46
1674Autologous Mesenchymal stem cells (MSCs)----1件: 2
1675Autologous mesenchymal stem cells derived from bone marrow----1件: 85
1676Autologous mesenchymal stromal cell----2件: 96, 298
1677Autologous MSC-NTF cells----1件: 2
1678Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population----1件: 96
1679Autologous Plasmablasts----1件: 19
1680Autologous Plasmablasts (B cells)----1件: 19
1681Autologous Regulatory ?-cells----1件: 51
1682Autologous serum----1件: 53
1683Autologous Serum 20%----1件: 53
1684Autologous Serum 50%----1件: 53
1685Autologous Stem Cell----1件: 8
1686Autologous Stem Cell Transplant----2件: 53, 56
1687Autologous Stem Cell Transplantation----2件: 56, 96
1688Autologous Stem Cells----2件: 13, 51
1689Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51
1690Autologous Stromal Vascular Fraction (SVF)----1件: 85
1691Autologous stromal vascular fraction cells----1件: 46
1692AUTOLOGOUS T-LYMPHOCYTES----1件: 13
1693Autologous T-regulatory lymphocytes----1件: 2
1694Autologous Tissue-Engineered Vascular Graft----1件: 210
1695Autologous Umbilical Cord Blood----2件: 211, 294
1696Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)1件: Myelin basic protein---1件: 13
1697AV-1011件: AV-101---2件: 6, 86
1698AV1451 Tau----1件: 127
1699AV605----1件: 13
1700Avacincaptad pegol1件: Avacincaptad pegol---1件: 301
1701Avacopan1件: Avacopan1件: D11093 1件: C5AR1 💬6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬3件: 43, 44, 222
1702Avalglucosidase Alfa1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1703Avalglucosidase alfa (GZ402666)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1704Avalglucosidase Alfa (NeoGAA)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1705Avalglucosidase alfa GZ4026661件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1706Avalglucosidase alfa-NGPT (GZ402666)1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1707Avalglucosidase alfa-NGPT (GZ402666) IV1件: Avalglucosidase alfa1件: D11744 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1708Avalglucosidasi alfa----1件: 256
1709Avalotcagene ontaparvovec1件: Avalotcagene ontaparvovec---1件: 251
1710AVALOX - 400----1件: 6
1711Avandia administration for 6-12 weeks----1件: 265
1712AVASTIN1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227
1713AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227
1714Avatrombopag1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬2件: 60, 63
1715Avatrombopag (proposed)1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1716Avatrombopag 20 MG1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 60
1717Avatrombopag 20 MG Oral Tablet1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 60
1718AVATROMBOPAG MALEATE1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1719Avatrombopag tablets1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
1720AVB-114----1件: 96
1721AVB-S6-500----1件: 66
1722AVCN583601 (3% Cannabidiol cream)1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 36
1723Avdoralimab1件: Avdoralimab---1件: 162
1724Avdoralimab (IPH5401)1件: Avdoralimab---1件: 162
1725AVE8112----1件: 6
1726AVE9897----1件: 46
1727Avelox- Moxifloxacin1件: Moxifloxacin1件: D08237 --1件: 46
1728Avelox®1件: Moxifloxacin1件: D08237 --1件: 46
1729AVI-4658----1件: 113
1730AVI-4658 (Eteplirsen)1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
1731AVI-4658 (PMO)----1件: 113
1732AVI-4658 for Injection----1件: 113
1733Avian polyclonal IgY antibody against PA----1件: 299
1734Avibactam1件: Avibactam---1件: 299
1735AVID200----1件: 51
1736Aviptadil1件: Aviptadil1件: D12127 --5件: 49, 51, 84, 85, 86
1737Aviptadil, 66 microgram/mL1件: Aviptadil1件: D12127 --1件: 85
1738AVONEX1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97
1739Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1740Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1741AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1742Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1743AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1744Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1745AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1746Avonex and Topamax1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1747AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1748AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1749Avonex/Betaseron/Copaxone/Rebif3件: Glatiramer,
Interferon beta-1a,
Interferon beta-1b		2件: D00746 ,
D04554 		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1750Avonex/Zocor1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1751AVONEX®1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1752Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
1753AVP-923----3件: 2, 6, 13
1754AVP-923-45----1件: 6
1755AVR-RD-01----1件: 19
1756AVR-RD-02----1件: 19
1757AVTX-803----1件: 65
1758AVTX-803 (L-Fucose)1件: Fucose---1件: 65
1759AVX 470----1件: 97
1760AVXS-101----1件: 3
1761AVXS-101 (previously known as scAAV9.CB.SMN)----1件: 3
1762AX----1件: 19
1763AX 250----1件: 19
1764Axitinib1件: Axitinib1件: D03218 3件: FLT1,
FLT4,
KDR 💬		15件: Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34
1765AXO-AAV-GM2 High Dose----1件: 19
1766AXO-AAV-GM2 Low Dose----1件: 19
1767AXO-AAV-GM2 Middle Dose----1件: 19
1768AXO-AAV-GM2 Starting Dose----1件: 19
1769AZA----4件: 11, 40, 96, 97
1770AZA capsules----1件: 96
1771AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL----1件: 97
1772AZAFOR 50mg----1件: 97
1773AZAPRED----1件: 85
1774Azathioprin----2件: 46, 96
1775Azathioprin-ratiopharm 25 mg----1件: 96
1776Azathioprin-ratiopharm 25mg Filmtabletten----1件: 96
1777Azathioprin-ratiopharm 50 mg Filmtabletten----1件: 96
1778Azathioprin-ratiopharm® 25 mg Filmtabletten----1件: 44
1779Azathioprine1件: Azathioprine1件: D00238 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
1780Azathioprine (AZA)1件: Azathioprine1件: D00238 --3件: 13, 19, 97
1781Azathioprine (AZA) caps1件: Azathioprine1件: D00238 --1件: 96
1782Azathioprine (AZA) or 6-mercaptopurine (6-MP)2件: Azathioprine,
Mercaptopurine		3件: D00161 ,
D00238 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97
1783Azathioprine (Imuran) 50 mg Overencapsulated Tablet1件: Azathioprine1件: D00238 --1件: 97
1784Azathioprine + infliximab2件: Azathioprine,
Infliximab		2件: D00238 ,
D02598 		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
1785Azathioprine - ratiopharm 50 mg1件: Azathioprine1件: D00238 --1件: 96
1786Azathioprine / 6 Mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: D00161 ,
D00238 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96
1787Azathioprine 25 mg1件: Azathioprine1件: D00238 --1件: 44
1788Azathioprine and Allopurinol2件: Allopurinol,
Azathioprine		2件: D00224 ,
D00238 		1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 97
1789AZATHIOPRINE BP1件: Azathioprine1件: D00238 --1件: 97
1790Azathioprine in case of endoscopic recurrence1件: Azathioprine1件: D00238 --1件: 96
1791Azathioprine individualised dose1件: Azathioprine1件: D00238 --1件: 96
1792Azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: D00161 ,
D00238 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97
1793Azathioprine or adalimumab and infliximab3件: Adalimumab,
Azathioprine,
Infliximab		3件: D00238 ,
D02597 ,
D02598 		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
1794Azathioprine OR Mesalazine2件: Azathioprine,
Mesalazine		2件: D00238 ,
D00377 		--1件: 96
1795AZATHIOPRINE or METHOTREXATE2件: Azathioprine,
Methotrexate		2件: D00142 ,
D00238 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96
1796Azathioprine or Mycophenolate mofetil3件: Azathioprine,
Mycophenolate mofetil,
Mycophenolic acid		3件: D00238 ,
D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162
1797Azathioprine weight-based dose1件: Azathioprine1件: D00238 --1件: 96
1798Azathioprine+enteral nutrition1件: Azathioprine1件: D00238 --1件: 96
1799Azathioprine/prednisone2件: Azathioprine,
Prednisone		2件: D00238 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 85
1800Azatioprina1件: Azathioprine1件: D00238 --3件: 13, 96, 97
1801AZATIOPRINA ASPEN - 50 COMPRESSE1件: Azathioprine1件: D00238 --1件: 96
1802AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine1件: D00238 --1件: 13
1803AZD0328----1件: 6
1804AZD0530----1件: 272
1805AZD1236----1件: 299
1806AZD2014----1件: 34
1807AZD3241----2件: 6, 17
1808AZD3241 100mg----1件: 17
1809AZD3241 300 mg BID----1件: 6
1810AZD3241 300mg----1件: 17
1811AZD3241 600 mg BID----1件: 6
1812AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6
1813AZD3241 ER formulation 1----1件: 6
1814AZD3241 Extended release tablets 100 mg1件: Manganese citrate---1件: 6
1815AZD3241 Extended release tablets 25 mg1件: Manganese citrate---1件: 6
1816AZD4017----1件: 75
1817AZD4017 and prednisolone1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
1818AZD4831----1件: 86
1819AZD5055----1件: 85
1820AZD5634----1件: 299
1821AZD5634 for infusion----1件: 299
1822AZD5634 for inhalation----1件: 299
1823AZD5672----1件: 46
1824AZD6244----1件: 34
1825AZD7325----1件: 206
1826AZD7325 (High-Dose)----1件: 206
1827AZD7325 (Low-Dose)----1件: 206
1828AZD7986----2件: 44, 299
1829AZD9056----2件: 46, 96
1830AZD9056 hydrochloride----1件: 46
1831AZD9567----1件: 46
1832AZD9567 10 mg----1件: 46
1833AZD9567 125 mg----1件: 46
1834AZD9567 155 mg----1件: 46
1835AZD9567 20 mg----1件: 46
1836AZD9567 40 mg----1件: 46
1837AZD9567 80 mg----1件: 46
1838AZD9567 Monohydrat----1件: 46
1839AZD9567 monohydrate----1件: 46
1840AZD9668----1件: 299
1841Azilect1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17
1842AZILECT 1 mg comprimidos1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17
1843Azilect 1mg1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1844AZILECT®1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1845AZILECT® 1 mg Tabletten1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 2
1846Azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
1847Azithromycin (Zitromax°)1件: Azithromycin2件: D06390 ,
D07486 		--1件: 228
1848Azithromycin + Metronidazole2件: Azithromycin,
Metronidazole		3件: D00409 ,
D06390 ,
D07486 		--1件: 96
1849Azithromycin + N-acetylcystein + inhaled corticosteroid1件: Azithromycin2件: D06390 ,
D07486 		--1件: 228
1850Azithromycin 250 mg tablets1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
1851Azithromycin 250Mg Capsule1件: Azithromycin2件: D06390 ,
D07486 		--1件: 84
1852Azithromycin 500 mg film-coated tablet1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
1853AZITHROMYCIN DIHYDRATE1件: Azithromycin2件: D06390 ,
D07486 		--2件: 228, 299
1854Azithromycin monohydrate1件: Azithromycin2件: D06390 ,
D07486 		--1件: 84
1855AZITHROMYCINE1件: Azithromycin2件: D06390 ,
D07486 		--1件: 228
1856AZITHROMYCINE 250 mg1件: Azithromycin2件: D06390 ,
D07486 		--1件: 228
1857AZLI----1件: 299
1858AZLI 75 mg three times a day (TID)----1件: 299
1859AZLI 75 mg three times daily (TID)----1件: 299
1860AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299
1861AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299
1862AZM----1件: 228
1863AZP-3601----1件: 235
1864AZP-531----1件: 193
1865AZP2006 oral solution----1件: 5
1866AZT----2件: 94, 265
1867AZT/3TC----1件: 265
1868Aztreonam1件: Aztreonam1件: D00240 --2件: 228, 299
1869Aztreonam for Inhalation (AI)1件: Aztreonam1件: D00240 --1件: 299
1870Aztreonam for Inhalation Solution1件: Aztreonam1件: D00240 --1件: 299
1871Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam1件: D00240 --1件: 299
1872AZTREONAM LYSINE2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
1873Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
1874Aztreonam Lysine for Inhalation (AZLI)2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 228
1875Aztreonam solución para inhalación1件: Aztreonam1件: D00240 --1件: 299
1876Aztreonan lysine1件: Lysine1件: D02304 --1件: 299
1877Aún no establecido----1件: 53